2AR-Adenylyl Cyclase
Pathway in Human Airway Smooth Muscle
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
2-Adrenergic receptors (
2ARs) are important regulators of airway smooth muscle tone, and
-sympathomimetic drugs are the most widely used agents in asthma therapy and are universally recognized as the
treatment of choice for acute asthma attacks. Despite the clinical importance of
-agonists and a good understanding of their mechanism of action in airway smooth muscle relaxation, surprisingly little is known
about the manner in which the
2AR signaling pathway is regulated in human airway smooth muscle
(HASM). In this communication, we characterize mechanisms underlying rapid desensitization of the
HASM
2AR-adenylyl cyclase (AC) pathway. Acute homologous desensitization of
2AR-mediated cyclic adenosine monophosphate (cAMP) production was characterized by an ~ 60% loss of maximal responsiveness to isoproterenol (ISO) when cells were pretreated for 30 min with 1 µM ISO. Acute heterologous
2AR desensitization was characterized by an ~ 20% and 30% loss of maximal responsiveness to
ISO challenge when cells were pretreated with forskolin and prostaglandin E2 (PGE2), respectively. Each form of desensitization was also characterized by an increase in the EC50 for ISO.
2AR sequestration was
associated with but not required for homologous desensitization. However, sequestration was required for
rapid resensitization. Minimal alterations in inherent AC activity were observed with both modes of desensitization, suggesting that the
2AR is the principal locus of regulation. Protein kinase inhibition by staurosporine largely reversed heterologous
2AR desensitization and had a small but significant effect on homologous desensitization. In contrast, bisindolylmaleimide IX, a specific PKC-inhibitor, had no effect on
heterologous or homologous
2AR desensitization, suggesting that staurosporine effects were mediated by
PKA inhibition. Overexpression of the G protein-coupled receptor kinase GRK2 in HASM cultures enhanced homologous desensitization. These data suggest that HASM
2ARs are highly susceptible to rapid desensitization by multiple agents, and identify both GRKs and PKA as important mediators of acute
2AR desensitization.
| |
Introduction |
|---|
|
|
|---|
Inhaled
-agonists are the most widely used agents in
asthma therapy and are universally recognized as the
treatment of choice for acute asthma attacks. When used
in asthma treatment,
-agonists mediate their effect primarily by activating
2-adrenergic receptors (
2ARs) on
airway smooth muscle.
2AR activation promotes G-protein (Gs) activation of adenylyl cyclase, an increase in intracellular cyclic adenosine monophosphate (cAMP), and
subsequent activation of protein kinase A (PKA). PKA
activation results in a host of intracellular effects that contribute to the relaxation of airway smooth muscle. Despite
the widespread use of
-agonists and a deep understanding of their mechanism of action in airway smooth muscle
relaxation, surprisingly little is known about the manner in
which the
2AR signaling pathway is regulated in human
airway smooth muscle (HASM). Alterations in
2AR responsiveness can be effected by mediators of inflammation, glucocorticoids, and
-agonists themselves, in a time-dependent and cell-specific manner (1). Indeed, the issue
of tachaphalaxis and the phenomenon of agonist-specific desensitization have been important considerations in
-agonist drug design (2, 3), and may also underlie important
clinical observations, such as the loss of prophylactic bronchoprotection and deterioration of asthma control (4).
Although numerous studies have identified impairment
of
2AR-mediated functions in human and nonhuman airway smooth muscle, only a handful of studies have examined the regulation of the HASM
2AR-adenylyl cyclase
(AC) signaling pathway per se. Mechanisms of acute (short-term) regulation of
2AR signaling identified in other systems have shown important roles for intracellular kinases
(G protein-coupled receptor kinases [GRKs], PKA, and/or protein kinase C [PKC]) in modulating the responsiveness
of this system.
2AR phosphorylation by PKA (induced
by agents that increase intracellular cAMP levels, and associated with heterologous desensitization) and by GRK2
(specific for the agonist-occupied receptor and associated with homologous desensitization) promote rapid uncoupling
of the
2AR from the stimulatory G protein Gs. However,
the extent to which either of these desensitization mechanisms is used appears to be highly cell-specific (8), and
may be related to kinase expression levels (9). In this report
we characterize the salient features of the acute regulation of
the
2AR-AC pathway in HASM cultures, and provide insight into the specific roles of GRKs and PKA in these processes. In addition, we present a technique enabling highly
efficient transfection of HASM cultures, which should facilitate the further analysis of molecular mechanisms of G protein-coupled receptor-pathway regulation in HASM.
| |
Materials and Methods |
|---|
|
|
|---|
Development of HASM Cultures
HASM cultures were established as described by Panettieri and colleagues (10) from human tracheae obtained from lung transplant donors, in accordance with procedures approved by the University of Pennsylvania Committee on Studies Involving Human Beings. Briefly, a segment of trachea superior to the carina was removed under sterile conditions, and the trachealis muscle was isolated. Approximately 0.5 g (wet tissue) of trachealis muscle was isolated from the distal trachea, minced, centrifuged, and resuspended in 10 ml of buffer containing 0.2 mM CaCl2, 640 U/ml collagenase, 1 mg/ml soybean trypsin inhibitor, and 10 U/ml elastase. Enzymatic dissociation of the tissue was done for 90 min in a shaking water bath at 37°C. The cell suspension was filtered through 105-µm Nytex mesh, and the filtrate was washed with equal volumes of cold Ham's F12 medium supplemented with 10% fetal bovine serum (FBS). Aliquots of the cell suspension were plated at a density of 104 cells/cm2 in Ham's F12 medium supplemented with 10% FBS, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 2.5 µg/ml amphotericin B. The medium was replaced every 72 h. Confluent cells in flasks were passaged with 0.25% trypsin/1 mM ethylenediaminetetraacetic acid (EDTA) at a plating density of 104 cells/cm2. Cells were maintained in serum-supplemented Ham's F12 medium for 12 d after passage. The medium was changed to serum-free medium (IT medium) containing 5 µg/ml transferrin and 5 µg/ml insulin 24 h before experimentation.
HASM cultures in subculture during the second to sixth
cell passages were used in the described experiments. During these cell passages, HASM cells retain native contractile protein expression, as shown by immunocytochemical
staining for smooth muscle actin and myosin (11), as well
as retaining functional cell-excitation coupling systems as
determined by fura-2 measurements of agonist-induced changes in cytosolic calcium (11, 12). Importantly, the stability of the
2AR-Gs-AC signaling pathway with repeated
cell passaging has been previously demonstrated (13).
Pretreatment of Cells
Cells grown to confluence on tissue-culture plates (12-well,
24-well, or 150-mm plates) were pretreated with IT medium ± vehicle (control) or the potential regulatory agent
(isoproterenol [ISO], forskolin [FSK], or prostaglandin E2
[PGE2]) for 30 min. In selected experiments, staurosporine (a potent inhibitor of both PKA and PKC), bisindolylmaleimide IX (Bis IX, a potent, specific inhibitor of PKC),
or concanavalin A (Con A, a lectin that blocks
2AR sequestration) were added to cultures 1 h (20 min for Con
A) before the 30-min pretreatment period. For studies examining
2AR resensitization, cells were washed thrice in
IT medium at 37°C and returned to the incubator for 1 h.
Following pretreatment or after recovery, cells in 12- or
24-well plates were placed on ice and washed thoroughly
with cold phosphate-buffered saline (PBS), then stimulated
as described subsequently. For studies assessing
2AR distribution in intact cells (receptor sequestration studies),
cells in 150-mm dishes were harvested by incubation with
0.25% trypsin/0.53 mM EDTA (± 1 µM ISO) during the final 2 min of the pretreatment period. Cells were then washed
extensively in ice-cold PBS and resuspended in PBS for
subsequent binding assay (see the following discussion).
Homogenate, Membrane Preparations
Cells were scraped from tissue-culture plates into ice-cold
homogenization buffer consisting of 25 mM Tris, pH 7.5;
5 mM EDTA; 1 mM ethyleneglycol-bis-(
-aminoethyl
ether)-N,N'-tetraacetic acid (EGTA); 0.02 mg/ml leupeptin; 0.2 mg/ml benzamidine; and 0.5 mM phenylmethylsulfonyl fluoride (PMSF), and were homogenized by Polytron
disruption. Membranes were prepared by centrifugation of
homogenates at 19,000 × g for 20 min at 4°C. Pellets were
resuspended in homogenization buffer using a glass-glass
dounce homogenizer, and were then washed twice by repeating the prior step of resuspension and centrifugation.
The final pellet was resuspended in homogenization buffer
and assayed immediately.
Whole-cell lysates used in immunoblot analysis were prepared by lysing cells in the homogenization buffer described previously containing 1% Triton X-100.
Protein concentrations from 12-well plates, cell suspensions, membrane preparations, and homogenates/lysates were determined with the Bradford assay (14).
2AR-binding Assays
For preliminary determination of
2AR density in HASM
cultures, approximately 100 µg of membrane protein were
incubated in a total volume of 500 µl of 25 mM Tris, pH 7.5, plus 2 mM MgCl2, containing ~ 5 to 200 pM [125I]iodopindolol (PIN) (2,200 Ci/mmol; NEN, Boston, MA) at 37°C for 1 h. Data were transformed according to Scatchard
(15) for estimation of receptor density and affinity for antagonist. In subsequent experiments,
2AR density in control and pretreated HASM cells was assessed by single-point
(200 pM [125I]PIN) analysis as previously described (16).
Nonspecific binding was determined by displacement of
[125I]PIN binding with 1 µM alprenolol.
In binding studies examining
2AR distribution in intact cells, 100 µg of harvested cells were incubated at 14°C
for 3.5 h with 200 pM [125I]PIN in the presence or absence
of 1 µM alprenolol (for determination of whole-cell
2AR
density) or 100 nM CGP 12177 (cell surface
2ARs), as
previously described (17).
All binding reactions were terminated by addition of five aliquots each 4 ml ice-cold 25 mM Tris-HCl, pH 7.5, plus 2 mM MgCl2, and filtration through Whatman GF/C filters, using a Brandel Cell Harvester (Gaithersburg, MD).
Measurement of cAMP Production
Experiments examining cAMP accumulation were done
with cells grown to confluence in 12- or 24-well plates in a
modification of the method described by Kong and coworkers (18). Individual wells were stimulated at 37°C
for 10 min with 500 µl PBS containing 300 µM ascorbic
acid and 1 mM isobutylmethylxanthine (IBMX) (excepting time-course studies) in the absence (basal) or presence
of either 10
9 to 10
4 M (
)ISO or 100 µM FSK. Preliminary studies were also done, using 1 mM RO-20-1724 (a
Type IV phosphodiesterase inhibitor); experimental effects of pretreatment with agonist and kinase inhibitor
were not influenced by the mode of phosphodiesterase inhibition (data not shown). Reactions were stopped by
placing the plates on ice, aspirating the media, and adding
500 µl of ice-cold ethanol. After a 1-h incubation at room
temperature, the ethanol from each well was transferred
to an Eppendorf tube. Samples were then lyophilized for
1 h, and the pellet was resuspended in 500 µl H2O and
stored at 4°C. We have determined that this method of
cAMP isolation slightly improves the reproducibility of results over that with methods using acid lysis and bicarbonate neutralization. Samples were assayed for cAMP content on the following day with a radioimmunoassay using a
[125I]cAMP tracer and cAMP antibody (provided by Dr.
M. Ascoli, University of Iowa) as previously described
(19). cAMP concentrations were determined by interpolation from a standard curve.
Transfection of HASM Cultures
HASM cells were transfected through a modification of
the procedure described by Forsayeth and Garcia (20), in
which a replication-deficient adenovirus (human adenovirus 5 dl343) is utilized to enhance 2-diethylaminoethanol (DEAE)-dextran-mediated transfection of cells that are
typically resistant to conventional methods of transfection.
For the present study we used the Ad5-guanine phosphotransferase (GPT) version of this virus (provided by P. Garcia) in which the entire E1A and E1B coding regions
are replaced by a GPT coding sequence. Briefly, 4 × 106
cells were harvested and resuspended in 5 ml of Dulbecco's minimal essential medium (DMEM) containing
200 µg of DEAE-dextran, 3 × 108 plaque-forming units of
Ad5-GPT, and 2 µg of each DNA to be transfected. The
mixture was plated onto 10-cm tissue-culture plates and
incubated for 2 h at 37°C. The medium was then removed,
the cells were washed for 1 min with 2 ml of 10% dimethylsulfoxide (DMSO) in Ca2+- and Mg2+-free PBS, and the
medium was replaced with serum-supplemented Ham's
F12 medium. From 20 to 24 h later the transfected cells were harvested and replated at high density (2 × 104 cells/
cm2) in 12-well plates or 150-mm plates, and were grown in
serum-supplemented medium. Transfection efficiency was
determined from 2 to 6 d after transfection by assessment
of
-galactosidase activity (21) in cells transfected with
pCMVneolacz, or by fluorescence-activated cell sorting
(FACS) analysis of expression of cotransfected pcDNA3- GFPS65T.
Preparation of Plasmids for Transfection
pcDNA3
2AR-flag was constructed by excising the open
reading frame of pBC-
2ARflag (provided by Dr. B. Kobilka, Stanford University) with SalI/HindIII, and the ~ 2-kb fragment was directionally cloned into pcDNA3.
pCMVneolacz was constructed by excising a 3.7-kb fragment from pAP-lacz (provided by A. Pronin, Thomas Jefferson University) with HindIII/XbaI, blunting the fragment with Klenow, and ligating the blunted fragment into pCMVneo. Correct orientation was confirmed by restriction analysis.
pcDNA3
ARK was constructed by excising an ~ 3-kb
HindIII fragment from the bovine
ARK clone
ARK3A
(22) and ligating into the HindIII site of pcDNA3.
pcDNA3-GFPS65T, encoding a variant of Aequorea victoria green fluorescent protein (Clontech, Palo Alto, CA), was provided by L. Kallal (Thomas Jefferson University).
Immunoblotting
From 20 to 30 mg of homogenate were electrophoresed on a 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel and transferred to a nitrocellulose membrane as previously described (23). The blot was washed in 20 mM Tris, pH 7.5, plus 150 mM NaCl (Tris-buffered saline; TBS), and was blocked for 1 h in TBS plus 0.05% Tween 20 (TTBS) with 5% (wt/vol) dried nonfat milk. The blot was then incubated for several hours with the primary monoclonal antibody 3A10 (which specifically recognizes GRK2) (23), and was subsequently washed thrice for 10 min each time with TTBS. The blot was subsequently incubated for 1 h with affinity-purified goat antimouse IgG conjugated to horseradish peroxidase, in 5% milk-TTBS. The blot was then washed thrice for 10 min each in TTBS, and was visualized through the enhanced chemiluminescence (ECL) technique (Amersham, Arlington Heights, IL).
Data Analysis
Data points from individual assays represent the mean values of duplicate or triplicate measurements. Dose-response
curves for ISO-mediated cAMP production were analyzed
by Sigmaplot (Jandel Corp., Chicago, IL) to obtain Vmax
and EC50 values. Except where indicated, cAMP generation was calculated as the increase in cAMP over basal levels and was expressed as a percentage of the values resulting from 100 µM FSK stimulation, to provide an index of
2AR coupling capacity (24). Statistically significant differences among groups were assessed with the t test for
paired samples, with values of P < 0.05 sufficient to reject
the null hypothesis. All experiments were designed such
that matched control conditions existed within each experiment to enable statistical comparison of paired samples.
| |
Results |
|---|
|
|
|---|
Characterization of
2AR Expression and
Signaling in HASM Cultures
Preliminary studies were done to establish the levels of
2AR receptor density and responsiveness to
-agonist of
HASM cultures. Saturation binding analyses of [125I]PIN
binding to HASM membranes from four separate cultures
demonstrated high-affinity binding (Kd values ranging
from 13 to 22 pM), with
2AR density ranging from 13 to
23 fmol/mg protein
values similar to those recently reported by Green and associates (25).
2AR density (fmol/
mg protein) in both intact whole-cell preparations and
whole-cell homogenate preparations was approximately
one-third that measured in membrane preparations from
the same culture (data not shown). Figure 1 shows the time-dependent cAMP response of HASM to stimulation with
1 µM ISO, 1 µM PGE2, and 100 µM FSK, which directly
activates AC (independently of
2AR activation). ISO
elicits rapid cAMP production in a linear manner for up to 7.5 to 10 min, after which the rate of cAMP accumulation
diminishes significantly, suggesting receptor desensitization.
A similar profile is observed for stimulation with PGE2, although absolute cAMP production is ~ 2-fold that observed
with ISO. In contrast, FSK-stimulated cAMP accumulation
is more linear throughout 20 min of stimulation. Absolute
values of ISO- and PGE2-stimulated cAMP production
among cultures were fairly consistent, whereas values of
FSK-stimulated cAMP displayed slightly greater variability. For the 15 different cultures utilized in these studies,
both
2AR density and cAMP responses were highly reproducible with repeated cell passaging (Passages two
through six were examined), as previously noted (13, 26).
|
Homologous and Heterologous Desensitization
of HASM
2AR
We next examined acute regulation of
2AR responsiveness by pretreating HASM cells for 30 min with 1 µM ISO,
0.1 µM PGE2, or 10 µM FSK, and observing the cAMP response to subsequent ISO challenge (Figure 2). ISO-pretreated cells displayed a large (~ 60%) reduction in maximal ISO-stimulated cAMP production, with a ~ 3-fold
increase in the EC50 value for ISO, an agonist-specific desensitization similar to that observed in the human airway
epithelial cell line BEAS-2B (16). FSK- and PGE2-pretreated cells each displayed a ~ 2-fold increase in EC50
values and a significant reduction (21% and 28%, respectively) in maximal cAMP production, suggesting that acute
PKA-mediated heterologous desensitization also occurs in
HASM cultures. FSK-stimulated cAMP production was relatively unaffected by pretreatment with ISO, FSK, or
PGE2, suggesting that desensitization is effected primarily
at the
2AR locus under these conditions (see Figure 2 legend). Although no other studies of acute
2AR regulation
in HASM cells exist for comparison, these results are in
general agreement with those of Hall and associates (13),
who demonstrated both homologous and heterologous
2AR desensitization following more chronic (1- to 24-h)
pretreatment conditions. Thus, our data suggest that both
forms of desensitization may be invoked in HASM, in contrast to our previous observations in both acutely dissociated (27) and immortalized (16) human airway epithelium,
in which mechanisms of heterologous desensitization were
shown to have minimal effects.
|
Role of Sequestration in HASM
2AR Regulation
The homologous desensitization shown in Figure 2 was associated with significant sequestration of cell-surface
2ARs.
Figure 3A depicts the time-dependent loss of cell surface
2ARs associated with acute exposure of HASM cultures
to 1 µM ISO.
2AR density was measured in intact cells
from [125I]iodopindolol binding, using either a hydrophobic or hydrophilic competitive antagonist to determine total and cell surface
2AR density, respectively. Cell surface
2AR density was calculated to be 82% of the total
receptor number. A rapid loss (~ 35%) of cell surface
2ARs was observed within 10 min of agonist exposure, with a loss of ~ 45% observed at 30 min. Only a minor
(< 10%) loss of total cell
2ARs was measured within the
30-min treatment period, showing that cell surface receptor loss was due to sequestration and not downregulation
(the latter of which is typically associated with chronic exposure to
-agonist). Several studies of numerous cell
types (28, 29) have shown that sequestration may be
blocked without affecting the initial rapid uncoupling of
the receptor from AC stimulation (and thus not contributing to desensitization per se). However, these studies typically examined cell types in which
2ARs were expressed
at high levels, in which case a significant receptor reserve
might confer tolerance of cell surface receptor loss. Because HASM cells express relatively low levels of
2ARs,
and
2AR signaling might therefore be affected by
2AR sequestration, we investigated whether blockage of
2AR
sequestration by pretreatment with Con A influenced the
pattern of homologous desensitization. As shown in Figure 3B, pretreatment with Con A had no significant effect on the dose-dependent response to ISO in either vehicle- (CON-) or ISO-pretreated cells. However, blockage
of
2AR sequestration with Con A produced a profound effect on the ability of HASM cells to recover from homologous desensitization. Following 30 min of pretreatment
with ISO, cells that were washed and allowed to incubate
an additional 60 min at 37°C (Figure 3B; RECOV) showed
a significantly increased Vmax value (~ 75% of CON) compared with the ISO-pretreated group. However, those
cells pretreated with Con A prior to the pretreatment/recovery phases (RECOV + Con A) exhibited little if any
resensitization. This finding suggests an apparent requirement of receptor recycling for rapid recovery from acute
homologous desensitization, and is consistent with the
finding in recent studies that implicate sequestration as
important in
2AR dephosphorylation and resensitization (30, 31).
|
Role of Protein Kinases in Acute
2AR Desensitization
To explore the potential role of intracellular kinases in
acute desensitization of the HASM
2AR, cells were pretreated with 1 µM staurosporine, a potent, membrane-permeable inhibitor of both PKA and PKC, for 1 h prior to 30 min pretreatment with FSK, PGE2, or ISO. As depicted by
the ISO dose-response curve in Figures 4A and 4B, staurosporine pretreatment largely reversed the heterologous desensitization observed in cells pretreated with FSK
(Vmax increased to 91 ± 3% from 81 ± 4% of CON value,
n = 4 paired observations) and PGE2 (92 ± 6% from 73 ± 3% of CON values; n = 5 paired observations). Staurosporine also had a small but statistically significant effect on homologous desensitization (Figure 4C), increasing the Vmax of the ISO dose-response curve to 50 ± 6% from 41 ± 4%
of CON values (n = 6 paired observations). Significant shifts
in EC50 values were also observed in the staurosporine-pretreatment groups for each of the pretreatment conditions
(FSK-D, PGE-D, or ISO-D; see Figure 4 legend).
|
Because staurosporine is a potent inhibitor of both
PKA and PKC, we further examined the potential role of
PKC in FSK-, PGE2-, and ISO-treated cells by pretreating
HASM cultures with Bis IX. Pretreatment with 1 µM Bis
IX had essentially no effect on either Vmax or EC50 values
in control or in FSK-, PGE2, and ISO-treated cells, with
dose-response curves for the four conditions being virtually superimposable (data not shown). These data suggest that the observed experimental effects of staurosporine
are mediated through inhibition of PKA, and that PKC
has no effect on either the heterologous
2AR desensitization mediated by activations of AC or on homologous desensitization in HASM.
Effect of GRK2 Overexpression on Agonist-specific
2AR Desensitization
In a comparison of the time course of ISO-stimulated
cAMP production in multiple types of lung cells, McGraw
and Liggett (9) recently demonstrated that a relatively low
level of GRK2 expression in HASM is associated with an attenuated rate of short-term agonist-promoted
2AR desensitization. This finding suggests that GRK2 levels may be
limiting in agonist-specific
2AR desensitization in HASM. We therefore hypothesized that increased expression of
GRK2 in HASM cells would enhance agonist-specific
2AR
desensitization.
To pursue this question it was first necessary to establish an effective technique for transient transfection of
HASM cultures. Traditionally, HASM cultures have been
difficult to transfect, because conventional methods (e.g.,
lipid-assisted or DEAE-dextran) produce extremely low
levels (1%) of transfection. We therefore used a modified
version of a technique recently described by Forsayeth and Garcia (20), in which DEAE-dextran is used to target
unmodified plasmid DNA to the cellular endocytotic pathway while a replication-deficient adenovirus facilitates lysis of the endocytotic vesicles. Application of this method
proved successful, resulting in high transfection efficiency
(typically ~ 50%) as assessed either from the activity of
expressed
-galactosidase (data not shown) or from cellular fluorescence of transfected green fluorescent protein as
determined by FACS (Figure 5A).
|
Transfection of HASM with pcDNA3
ARK, encoding
bovine GRK2, resulted in very high expression 3 d after
transfection, with somewhat attenuated expression still
observed 6 d after transfection (Figure 5B). The effect of
GRK2 overexpression on agonist-specific
2AR desensitization was subsequently investigated in multiple experiments, using transfected cells examined 3 d after transfection (Figure 6). GRK2 overexpression resulted in a small
but statistically significant increase in the loss of ISO-stimulated cAMP following ISO pretreatment. Overexpression of GRK2 in various cell types has been used to demonstrate a role for GRK2 in agonist-specific desensitization
of numerous receptors, including
2AR (32) and
1AR (33).
The present data support the notion advanced by McGraw and Liggett (9) that heterogeneity of GRK2 expression
among cell types as well as dynamic regulation of endogenous GRK2 levels may influence desensitization patterns.
|
| |
Discussion |
|---|
|
|
|---|
The purpose of this study was to characterize acute regulation of the
2AR-AC system in HASM cultures, and to
elucidate mechanisms by which desensitization of
2ARs
occurs. Thirty-minute pretreatment of HASM with either:
(1)
-agonist (inducing homologous desensitization); or
(2) agents that increased intracellular cAMP independently of
2AR activation (inducing heterologous desensitization) resulted in a loss of
2AR responsiveness to subsequent ISO challenge. Minimal alterations in FSK-stimulated
cAMP production were observed with both modes of desensitization, suggesting that the
2AR is the principal locus of regulation in HASM. Homologous desensitization was associated with but not dependent on a ~ 45% loss of
cell surface
2ARs. However, rapid recovery of
2AR responsiveness from homologous desensitization was highly
dependent on
2AR sequestration. Heterologous desensitization could be largely reversed by pretreatment of cells
with staurosporine, whereas a small but significant attenuation of homologous desensitization was observed with staurosporine pretreatment. Bis IX, a potent PKC inhibitor,
had no effect on
2AR desensitization, suggesting that the
effects of staurosporine were mediated through inhibition
of PKA. Overexpression of GRK2 in HASM cells enhanced
ISO-mediated desensitization, implicating GRK2 as a mediator of agonist-specific desensitization whose low level of
endogenous expression may limit the magnitude of desensitization in HASM cells.
Desensitization is a phenomenon in which cellular responsiveness is ultimately diminished when cells are subjected to a continuous stimulus. Desensitization of the
2AR-AC system characterized by diminished cAMP production has been studied in numerous expression systems
and cell lines. The mechanisms involved in regulating the
responsiveness of
2AR (and other G protein-coupled receptors) are cell-specific and complex; they include rapid alterations such as receptor phosphorylation (by PKA, GRKs,
or PKC), uncoupling from G protein, and sequestration,
which occur within minutes of agonist activation, as well as
slower changes that may involve increased receptor degradation and decreased receptor synthesis. Although changes
in receptor responsiveness may serve as the primary means
of desensitization, there is also evidence that G proteins and effector enzymes such as AC may be directly regulated
(for a comprehensive review of mechanisms of G protein-coupled receptor regulation, see Penn and Benovic [1]).
Despite the physiologic importance of
2AR stimulation in HASM function, the regulation of
2AR-mediated
signal transduction in HASM cells remains poorly understood. Alterations in
2AR-AC system function may occur in vivo during airway inflammation (through PKA- or
PKC-mediated mechanisms in association with heterologous desensitization) or with the repeated use of
-agonist
inhalers (agonist-specific or homologous desensitization)
in asthmatic individuals. Indeed, for years, speculation
about HASM
2AR desensitization has been a by-product
of clinical studies and pulmonary function analyses of the
effects of chronic
-agonist treatment on various measures
of airway responsiveness. Reports that systemic administration of
-agonists promotes
2AR downregulation in
peripheral blood cells, and more recent studies indicating
that inhaled
-agonists may also desensitize and/or downregulate
2ARs in peripheral blood (34), whole lung (35),
and airway epithelium (27, 36) have further advanced this
hypothesis. However, only a handful of studies have examined regulation of
2AR-Gs-AC cellular signaling in HASM.
In an interesting study that predated the identification of
many of the mechanisms involved in G protein-coupled receptor regulation, Davis and Conolly (37) noted reductions
in both ISO-mediated relaxation responses and cAMP
generation following 1 h pretreatment with ISO in bronchial strips obtained from carcinoma patients. In an analysis of effects of chronic
-agonist pretreatment in HASM
cultures, Hall and colleagues (13) observed a loss of AC responsiveness (cAMP generation) to subsequent ISO stimulation. Because pretreatment with FSK resulted in similar
but less impressive effects, the authors concluded that
mechanisms associated with both homologous and heterologous desensitization were probably involved. Green and
coworkers (25) have in part confirmed the findings of Hall
and colleagues in their characterization of chronic, agonist-specific desensitization and
2AR downregulation in HASM cultures expressing different
2AR polymorphisms. More
recent studies by Nogami and coworkers showed that chronic
exposure of HASM cultures to inflammatory mediators can
both desensitize (38) and sensitize (39)
-agonist-mediated
signaling, whereas phorbol ester activation of PKC sensitizes FSK stimulation of AC (39). However, the mechanisms of both acute and chronic
-agonist-induced
2AR
desensitization in HASM have so far remained largely uncharacterized, with the respective contributions of intracellular kinases to these processes unknown.
The present study identifies both heterologous and
homologous
2AR desensitization following short-term
treatment of HASM cultures. HASM cultures pretreated
with agents that increased intracellular cAMP either by direct activation of AC (FSK) or via a Gs-coupled receptor
(PGE2) exhibited a significant loss of
2AR responsiveness (20% to 30% loss of Vmax and a 2-fold increase in
EC50 values for ISO stimulation). These findings contrast
with those previously made in our studies of BEAS-2B
cells, in which pretreatment with either FSK or PGE2 elicited no change in Vmax and very small shifts in EC50 values
(16). Collectively, these findings suggest that airway cells
differ in their susceptibility to
2AR desensitization potentially elicited by local agents (e.g., inflammatory mediators) that activate AC.
A somewhat classical homologous
2AR desensitization was seen in HASM cultures, with a large reduction in
2AR responsiveness (~ 60% decrease in Vmax, ~ 3-fold
increase in EC50) being observed after 30 min pretreatment with ISO. Minimal alterations in FSK-stimulated cAMP (reflecting inherent AC activity) were observed,
suggesting that desensitization of the pathway occurs primarily at the level of
2AR-Gs coupling. Although alterations in Gs expression or function may contribute to the
observed desensitization, they seem unlikely for the following reasons: First, we have not observed any discernible
change in G
s expression as assessed by Western blotting
of either whole-cell homogenates or membrane preparations derived from HASM cells treated either acutely or chronically with
-agonist (data not shown). Second, Hall
and colleagues (13) observed that pretreatment of HASM
cultures with ISO did not significantly alter PGE2-mediated cAMP production, suggesting that Gs function remains
unaltered in ISO-treated HASM cells. Thus, the principal
locus of regulation appears to be the
2AR.
Acute homologous desensitization of HASM
2ARs
was shown to be associated with a ~ 45% loss of cell surface
2ARs. Although the relatively low level of
2AR expression in HASM raises the intriguing possibility that
sequestration may play a causal role in homologous desensitization in these cells, we were unable to detect any significant change in desensitization in cells pretreated with
Con A. However, we were able to determine a significant
effect of Con A pretreatment on the resensitization of
2AR signaling in HASM cultures. Cells allowed to recover for 1 h from the 30-min ISO treatment demonstrated
a clear enhancement of responsiveness (to 75% from 40%
of CON Vmax values), whereas recovering cells previously
treated with Con A exhibited little if any recovery of responsiveness. Thus, despite extremely low levels of
2AR expression, HASM cells appear similar to many cell lines/
expression systems expressing high levels of
2AR in demonstrating no requirement for
2AR sequestration for acute
homologous desensitization, but an apparent requirement
of receptor recycling in order to facilitate rapid recovery
of
2AR responsiveness.
The most extensively studied mechanisms of rapid
2AR desensitization involve receptor phosphorylation by
GRKs and PKA, which serve to uncouple the receptor
from Gs. However, each kinase has distinct mechanisms of
activation. PKA activation can be effected by any agent
that increases intracellular cAMP and may thus promote
2AR phosphorylation and desensitization independent of
2AR occupancy.
ARK, or GRK2, the best-characterized member of a recently established family of related G
protein-coupled receptor kinases (1, 40), specifically phosphorylates the agonist-occupied form of
2AR. Agonist
activation of the
2AR invokes G protein 
subunit-mediated translocation of GRK2 from the cytosol to the plasma
membrane (41). In addition to promoting
2AR uncoupling,
ARK phosphorylation of
2AR initiates the subsequent binding of arrestin proteins to
2AR (42, 43), further
uncoupling the receptor and facilitating
2AR sequestration via clathrin-mediated endocytosis (17, 44).
Although many cells appear capable of invoking both
PKA- and GRK2-mediated mechanisms of desensitization, early studies suggested that although PKA appeared
to be the fundamental regulator of heterologous desensitization, its role in
-agonist-mediated desensitization was
minimal if not inconsequential. This notion stemmed from
the observations that the extent of
-agonist-mediated
2AR
phosphorylation (45) and desensitization (45) were similar among wild-type, cyc- (which lack Gs), and kin- (which
lack PKA) s49 lymphoma cells. A subsequent study by Roth
and associates (50) of the kinetics of
2AR phosphorylation and desensitization in A431 cells concluded that GRK2-mediated phosphorylation was the most rapid and quantitatively important process contributing to rapid desensitization. However, these conclusions were not entirely supported by other studies using other cell types or expression
systems with mutant
2ARs that lack consensus PKA or
GRK2 phosphorylation sites (24, 51, 52). Using antisense
oligonucleotides targeting PKA and GRK2 in multiple cell
types, Shih and Malbon (8) recently reported that agonist-induced
2AR desensitization in Chinese hamster ovary cells and DDT1MF-2 smooth muscle cells is largely mediated by
ARK, desensitization in rat osteosarcoma cells appears to depend predominantly on PKA activity, and PKA
and
ARK appear equally effective in A431 cells. Utilizing an alternative approach to assess
2AR-Gs coupling,
Post and colleagues (53) recently showed that high-affinity
[3H]FSK binding (an index of receptor-activated Gs-AC
association) is significantly greater in kin-s49 lymphoma
cells than in wild-type cells following
-agonist pretreatment, suggesting that PKA plays an important role in the
agonist-promoted uncoupling of
2AR.
Our data suggest that PKA is probably the principal
regulator of FSK- and PGE2-mediated
2AR desensitization in HASM as evidenced by the ability of staurosporine
(a potent inhibitor of PKA and PKC), but not Bis IX (a
potent PKC-specific inhibitor), to attenuate the observed
desensitization. Staurosporine (but not Bis IX) also significantly, albeit to a much lesser degree, attenuated ISO-induced
2AR desensitization. We can therefore attribute
to PKA a small but decided role in modulating homologous
2AR desensitization in HASM cells. One potential
explanation for an observable role of PKA in the homologous desensitization of HASM
2AR may be a relatively
lesser capacity (compared with that in other cell types) of
GRK2 to invoke agonist-mediated desensitization. McGraw
and Liggett (9) have recently suggested that relatively low
levels of GRK2 expression in HASM contribute to a relatively slow rate of HASM
2AR desensitization. In the
present study, overexpression of GRK2 in HASM cultures
resulted in a small but significant enhancement of ISO-
induced desensitization, consistent with the hypothesis that
GRK2 may be limiting in HASM cells and thus may contribute to a small degree of resistance to homologous desensitization of
2AR. Our results, consistent with findings
in previous studies (9, 54, 55), suggest that regulation of
GRK2 expression in HASM (perhaps via chronic use of
-agonist inhalers) may modulate the degree of
2AR desensitization. On the other hand, the possibility also exists that
other protein kinases (such as PKA or other GRKs) confer
plasticity on this system and adequately compensate for a
low level of GRK2 activity. To date, we have been able to
identify proteins in HASM lysates immunoreactive to two
separate antibodies, one specifically directed against GRK5/
GRK6, and another specifically directed against GRK6 (unpublished observations). Thus, GRK5 and/or GRK6 also
may play important roles in homologous desensitization of
the HASM
2AR. Future studies of the specificity of GRKs
in HASM should help delineate further the respective roles
of protein kinases in the regulation of G-protein-coupled
receptors in HASM.
| |
Footnotes |
|---|
Address correspondence to: Raymond B. Penn, Thomas Jefferson University, Kimmel Cancer Institute, Rm. 930 B.L.S.B., 233 S. 10th St., Philadelphia, PA 19107. E-mail: rpenn{at}lennon.jci.tju.edu
(Received in original form May 16, 1997 and in revised form December 3, 1997).
Dr. Benovic is the recipient of American Heart Association Established Investigator Award.Acknowledgments: The authors thank A. Eszterhas for his valuable contributions in establishing and maintaining HASM cultures; Drs. A. Gagnon, L. Kallal, and A. Pronin for cDNA constructs; Dr. M. Ascoli for providing cAMP antibody; and Dr. P. Garcia for providing Ad5-GPT and advice on transfection procedures.
Supported in part by grants HL58506, GM44944, HL02647, and HL55301 from the National Institutes of Health, and NASA (NRA-OLMSA).
Abbreviations
AC, adenyl cyclase;
2AR,
2-adrenergic receptor;
EDTA, ethylenediaminetetraacetic acid;
FSK, forskolin;
GRK, G-protein-coupled receptor;
HASM, human airway smooth muscle;
ISO, isoproterenol;
PGE2, prostaglandin E2.
| |
References |
|---|
|
|
|---|
1. Penn, R. B., and J. L. Benovic. 1998 Desensitization of G protein-coupled receptors. In Handbook of Physiology, Vol. 1. P. M. Conn, editor. Oxford University Press, New York. 125-164.
2. Jack, D.. 1991. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol, and other beta-adrenoceptor agonists. Br. J. Clin. Pharmacol. 31: 501-514 [Medline].
3.
Johnson, M..
1995.
Pharmacology of long-acting
-agonists.
Ann. Allergy
Asthma Immunol.
75:
177-179
[Medline].
4. Cockcroft, D. W., C. P. McParland, S. A. Britto, V. A. Swystun, and B. C. Rutherford. 1993. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342: 833-837 [Medline].
5. Sears, M. R., D. R. Taylor, C. G. Print, D. C. Lake, Q. Li, E. M. Flannery, D. M. Yates, M. K. Lucas, and G. P. Herbison. 1990. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391-1396 [Medline].
6.
Spitzer, W. O.,
S. Suissa,
P. Ernst,
R. I. Horwitz,
B. Habbick,
D. Cockroft,
J.-F. Boivin,
M. McNutt,
A. S. Buist, and
A. S. Rebuck.
1992.
The use of
-agonists and the risk of death and near-death from asthma.
N. Engl. J. Med.
326:
501-506
[Abstract].
7. Vathenen, A. S., B. G. Higgins, A. J. Knox, J. R. Britton, and A. E. Tattersfield. 1988. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1: 554-558 [Medline].
8.
Shih, M., and
C. C. Malbon.
1994.
Oligodeoxynucleotides antisense to
mRNA encoding protein kinase A, protein kinase C, and
-adrenergic receptor kinase reveal distinctive cell-type specific roles in agonist-induced
desensitization.
Proc. Natl. Acad. Sci. USA
91:
12193-12197
9.
McGraw, D. W., and
S. B. Liggett.
1997.
Heterogeneity in
-adrenergic receptor kinase in the lung accounts for cell-specific desensitization of the
2-adrenergic receptor.
J. Biol. Chem.
272:
7338-7344
10. Panettieri, R. A., R. K. Murray, L. R. DePalo, P. A. Yadvish, and M. I. Kotlikoff. 1989. A human smooth muscle cell line that retains physiological responsiveness. Am. J. Physiol. 256 (Cell. Physiol. 25):C329-C335.
11. Panettieri, R. A. 1994. Airway smooth muscle cell growth and proliferation. In Airway Smooth Muscle: Development, Regulation, and Contractility. D. Raeburn and M. A. Giembycz, editors. Birkhauser Verlag, Basel.
12. Murray, R. K., B. K. Fleischmann, and M. I. Kotlikoff. 1993. Receptor-activated Ca2+ influx in human airway smooth muscle: use of Ca2+ imaging and perforated patch-clamp techniques. Am. J. Physiol. 264 (Cell. Physiol. 33):C485-C490.
13.
Hall, I. P.,
K. Daykin, and
S. Widdop.
1993.
2-adrenoceptor desensitization
in cultured human airway smooth muscle.
Clin. Sci.
84:
151-157
[Medline].
14. Bradford, M.. 1976. A rapid and sensitive method for the quantification of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254 [Medline].
15. Scatchard, G.. 1949. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660-672 .
16.
Penn, R. B.,
S. G. Kelsen, and
J. L. Benovic.
1994.
Regulation of
-agonist-
and prostaglandin E2-mediated adenylyl cyclase activity in human airway
epithelial cells.
Am. J. Respir. Cell Mol. Biol.
11:
496-505
[Abstract].
17.
Ferguson, S. S. G.,
W. E. I. Downey,
A.-M. Colapietro,
L. S. Barak,
L. Menard, and
M. G. Caron.
1996.
Role of
-arrestin in mediating agonist-promoted G protein-coupled receptor internalization.
Science
271:
363-365
[Abstract].
18.
Kong, G.,
R. Penn, and
J. L. Benovic.
1994.
A
-adrenergic receptor kinase
dominant negative mutant attenuates desensitization of the
2-adrenergic
receptor.
J. Biol. Chem.
269:
13084-13087
19.
Pereira, M. E.,
D. L. Segaloff,
M. Ascoli, and
F. Eckstein.
1987.
Inhibition
of choriogonadotropin-activated steroidogenesis in cultured Leydig tumor
cells by the Rp diastereoisomer of adenosine 3',5'-cyclic phosphorothiate.
J. Biol. Chem.
262:
6093-6100
20. Forsayeth, J. R., and P. B. Garcia. 1994. Adenovirus-mediated transfection of cultured cells. Biotechniques 17: 354-359 [Medline].
21. Lim, K., and C. B. Chae. 1989. A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase. Biotechniques 7: 576-579 [Medline].
22.
Benovic, J. L.,
A. De Blasi,
W. C. Stone,
M. G. Caron, and
R. J. Lefkowitz.
1989.
-adrenergic receptor kinase: primary structure delineates a multigene family.
Science
246:
235-240
23.
Loudon, B.,
B. Perussia, and
J. L. Benovic.
1996.
Differentially regulated
expression of the G protein-coupled receptor kinases,
ARK and GRK6,
during myelomonocytic cell development in vitro.
Blood
88:
4547-4557
24.
Lohse, M. J.,
J. L. Benovic,
M. G. Caron, and
R. J. Lefkowitz.
1990.
Multiple pathways of rapid
2-adrenergic receptor desensitization. Delineation
with specific inhibitors.
J. Biol. Chem.
265:
3202-3209
25.
Green, S. A.,
J. Turki,
P. Bejarano,
I. P. Hall, and
S. B. Liggett.
1995.
Influence of
2-adrenergic receptor genotypes on signal transduction in human
airway smooth muscle cells.
Am. J. Respir. Cell Mol. Biol.
13:
25-33
[Abstract].
26.
Hall, I. P., and
M. Kotlikoff.
1995.
Use of cultured airway myocytes for
study of airway smooth muscle.
Am. J. Physiol.
268:
L1-L11
27.
Penn, R. B., J. R. Shaver, J. G. Zangrilli, M. Pollice, J. E. Fish, S. P. Peters,
and J. L. Benovic. 1996. Effects of inflammation and acute beta-agonist inhalation on
2-adrenergic receptor signaling in human airways. Am. J. Physiol. 271 (Lung Cell Mol. Physiol. 15):L601-L608.
28.
Homburger, V.,
M. Lucas,
B. Cantau,
J. Barabe,
J. Penit, and
J. Bockaert.
1980.
Further evidence that desensitization of beta-adrenergic-sensitive
adenylate cyclase proceeds in two steps: modification of the coupling and
loss of beta-adrenergic receptors.
J. Biol. Chem.
255:
10436-10444
29.
Waldo, G. L.,
J. K. Northup,
J. P. Perkins, and
T. K. Harden.
1983.
Characterization of an altered membrane form of the
-adrenergic receptor produced during agonist-induced desensitization.
J. Biol. Chem.
258:
13900-13908
30.
Yu, S. S., and
R. J. Lefkowitz.
1993.
-adrenergic receptor sequestration: a
potential mechanism of receptor resensitization.
J. Biol. Chem.
268:
337-341
31. Pippig, S., S. Andexinger, and M. J. Lohse. 1995. Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol. Pharmacol. 47: 666-676 [Abstract].
32.
Pippig, S.,
S. Andexinger,
K. Daniel,
M. Puzicha,
M. G. Caron,
R. J. Lefkowitz, and
M. J. Lohse.
1993.
Overexpression of
-arrestin and
-adrenergic receptor kinase augment desensitization of
2-adrenergic receptor.
J. Biol. Chem.
268:
3201-3208
33.
Freedman, N. J.,
S. B. Liggett,
D. E. Drachman,
G. Pei,
M. G. Caron, and
R. J. Lefkowitz.
1995.
Phosphorylation and desensitization of the human
1-adrenergic receptor.
J. Biol. Chem.
270:
17953-17961
34.
Schuster, A.,
R. Kozlik, and
D. Reinhardt.
1991.
Influence of short- and
long-term inhalation of salbutamol on lung function and
2-adrenoceptors
of mononuclear blood cells in asthmatic children.
Eur. J. Pediatr.
150:
209-213
[Medline].
35. Hayes, M., F. Qing, C. G. Rhodes, P. W. Ind, T. Jones, and J. M. B. Hughes. 1994. Effect of two weeks of salbutamol on human pulmonary beta-adrenergic receptor number and airway function. Eur. Respir. J. 7: 235s .
36.
Turki, J., S. A. Green, K. B. Newman, M. A. Meyers, and S. B. Liggett.
1995. Human lung cell
2-adrenergic receptors desensitize in response to
in vivo administered
-agonist. Am. J. Physiol. 269(Lung Cell. Mol. Physiol. 5):L709-L714.
37. Davis, C., and M. E. Conolly. 1980. Tachyphylaxis to beta-adrenoceptor agonists in human bronchial smooth muscle: studies in vitro. Br. J. Clin. Pharmacol. 10: 417-423 [Medline].
38.
Nogami, M., D. J. Romberger, S. I. Rennard, and M. L. Toews. 1994. TGF-
1
modulates
-adrenergic receptor number and function in cultured human
tracheal smooth muscle cells. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol.
10):L187-L191.
39. Nogami, M., S. M. Whittle, D. J. Romberger, S. I. Rennard, and M. Toews. 1995. Lysophosphatidic acid regulation of cyclic AMP accumulation in cultured human airway smooth muscle cells. Mol. Pharmacol. 48: 766-773 [Abstract].
40. Sterne-Marr, R., and J. L. Benovic. 1995. Regulation of G protein-coupled receptors by receptor kinases and arrestins. In Vitamins and Hormones. G. Litwack, editor. Academic Press, New York. 193-234.
41.
Pitcher, J. A.,
J. Inglese,
J. B. Higgins,
J. L. Arriza,
P. J. Casey,
C. Kim,
J. L. Benovic,
M. M. Kwatra,
M. G. Caron, and
R. J. Lefkowitz.
1992.
Role of

subunits of G proteins in targeting the
-adrenergic receptor kinase to
membrane-bound receptors.
Science
257:
1264-1267
42.
Lohse, M. J.,
J. L. Benovic,
M. G. Caron, and
R. J. Lefkowitz.
1990.
-Arrestin: a protein that regulates
-adrenergic receptor function.
Science
248:
1547-1550
43.
Gurevich, V. V.,
S. B. Dion,
J. J. Onorato,
J. Ptasienski,
C. M. Kim,
R. Sterne-Marr,
M. M. Hosey, and
J. L. Benovic.
1995.
Arrestin interactions
with G protein-coupled receptors: direct binding studies of wild-type, truncated, and chimeric arrestins with rhodopsin,
2-adrenergic, and m2 muscarinic cholinergic receptors.
J. Biol. Chem.
270:
720-731
44. Goodman, O. B., J. G. Krupnick, F. Santini, V. V. Gurevich, R. B. Penn, A. W. Gagnon, J. H. Keen, and J. L. Benovic. 1996. Beta-arrestin acts as a clathrin adaptor protein in endocytosis of the beta-2-adrenergic receptor. Nature 383: 447-450 [Medline].
45. Strasser, R. H., D. R. Sibley, and R. J. Lefkowitz. 1986. A novel catecholamine-activated adenosine cyclic 3',5'-phosphate independent pathway for b-adrenergic receptor phosphorylation in wild-type and mutant s49 lymphoma cells: mechanism of homologous desensitization of adenylate cyclase. Biochemistry 25: 1371-1377 [Medline].
46. Green, D. A., J. Friedman, and R. B. Clark. 1981. Epinephrine desensitization of adenylate cyclase from cyc- and s49 cultured lymphoma cells. J. Cyclic Nucleotide Res. 7: 161-172 [Medline].
47.
Green, D. A., and
R. B. Clark.
1981.
Adenylate cyclase coupling proteins
are not essential for agonist-specific desensitization of lymphoma cells.
J.
Biol. Chem.
256:
2105-2108
48.
Shear, M.,
P. A. Insel,
K. L. Melmon, and
P. Coffino.
1976.
Agonist-specific
refractoriness induced by isoproterenol: a study with mutant cells.
J. Biol.
Chem.
251:
7572-7576
49.
Insel, P. A.,
L. C. Mahan,
H. J. Motulsky,
L. M. Stoolman, and
A. M. Koachman.
1983.
Time-dependent decreases in binding affinity of agonists
for
-adrenergic receptors of intact s49 lymphoma cells: a mechanism of
desensitization.
J. Biol. Chem.
258:
13597-13605
50.
Roth, N. S.,
P. T. Campbell,
M. G. Caron,
R. J. Lefkowitz, and
M. J. Lohse.
1991.
Comparative rates of desensitization of
-adrenergic receptors by
the
-adrenergic receptor kinase and the cyclic AMP-dependent protein
kinase.
Proc. Natl. Acad. Sci. USA
88:
6201-6204
51.
Liggett, S. B.,
M. Bouvier,
W. P. Hausdorff,
B. F. O'Dowd,
M. G. Caron, and
R. J. Lefkowitz.
1989.
Altered patterns of agonist-stimulated cAMP
accumulation in cells expressing mutant
2-adrenergic receptors lacking
phosphorylation sites.
Mol. Pharmacol.
36:
641-646
[Abstract].
52.
Hausdorff, W. P.,
M. Bouvier,
B. F. O'Dowd,
G. P. Irons,
M. G. Caron, and
R. J. Lefkowitz.
1989.
Phosphorylation sites on two domains of the
2-adrenergic receptor are involved in distinct pathways of receptor desensitization.
J. Biol. Chem.
264:
12657-12665
53.
Post, S. R.,
O. Aguila-Buhain, and
P. Insel.
1996.
A key role for protein kinase A in homologous desensitization of the
2-adrenergic receptor pathway in s49 lymphoma cells.
J. Biol. Chem.
271:
895-900
54.
Choi, D. J.,
W. J. Koch,
J. J. Hunter, and
H. A. Rockman.
1997.
Mechanism
of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase.
J. Biol. Chem.
272:
17223-17229
55.
Ungerer, M.,
M. Bohm,
J. S. Elce,
E. Erdmann, and
M. J. Lohse.
1993.
Altered expression of the
-adrenergic receptor kinase and
1-adrenergic receptors in failing human heart.
Circulation
87:
454-463
This article has been cited by other articles:
![]() |
G. Nino, A. Hu, J. S. Grunstein, and M. M. Grunstein Mechanism regulating proasthmatic effects of prolonged homologous {beta}2-adrenergic receptor desensitization in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L746 - L757. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Fairbank, S. C. Connolly, J. D. MacKinnon, K. Wehry, L. Deng, and G. N. Maksym Airway smooth muscle cell tone amplifies contractile function in the presence of chronic cyclic strain Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L479 - L488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hu, G. Nino, J. S. Grunstein, S. Fatma, and M. M. Grunstein Prolonged heterologous {beta}2-adrenoceptor desensitization promotes proasthmatic airway smooth muscle function via PKA/ERK1/2-mediated phosphodiesterase-4 induction Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1055 - L1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, V. De Arcangelis, X. Gao, B. Ramani, Y.-s. Jung, and Y. Xiang Norepinephrine- and Epinephrine-induced Distinct 2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes J. Biol. Chem., January 25, 2008; 283(4): 1799 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Willoughby, G. S. Baillie, M. J. Lynch, A. Ciruela, M. D. Houslay, and D. M. F. Cooper Dynamic Regulation, Desensitization, and Cross-talk in Discrete Subcellular Microdomains during beta2-Adrenoceptor and Prostanoid Receptor cAMP Signaling J. Biol. Chem., November 23, 2007; 282(47): 34235 - 34249. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, J.-C. Dai, and E. M. Greenfield Termination of immediate-early gene expression after stimulation by parathyroid hormone or isoproterenol Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1432 - C1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Pascual, C. K. Billington, I. P. Hall, R. A. Panettieri Jr., J. E. Fish, S. P. Peters, and R. B. Penn Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1425 - L1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. KIPS and R. A. PAUWELS Long-acting Inhaled beta 2-Agonist Therapy in Asthma Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 923 - 932. [Full Text] [PDF] |
||||
![]() |
T. A. Wyatt and J. H. Sisson Chronic ethanol downregulates PKA activation and ciliary beating in bovine bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L575 - L581. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Billington, R. M. Pascual, M. L. Hawkins, R. B. Penn, and I. P. Hall Interleukin-1{beta} and Rhinovirus Sensitize Adenylyl Cyclase in Human Airway Smooth-Muscle Cells Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 633 - 639. [Abstract] [Full Text] |
||||
![]() |
V. P. Krymskaya, A. J. Ammit, R. K. Hoffman, A. J. Eszterhas, and R. A. Panettieri Jr. Activation of class IA PI3K stimulates DNA synthesis in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L1009 - L1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Mundell, M. E. Olah, R. A. Panettieri Jr., J. L. Benovic, and R. B. Penn Regulation of G Protein-Coupled Receptor-Adenylyl Cyclase Responsiveness in Human Airway Smooth Muscle by Exogenous and Autocrine Adenosine Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 155 - 163. [Abstract] [Full Text] |
||||
![]() |
A. J. Ammit, R. K. Hoffman, Y. Amrani, A. L. Lazaar, D. W. P. Hay, T. J. Torphy, R. B. Penn, and R. A. Panettieri Jr. Tumor Necrosis Factor-alpha -Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth-Muscle Cells . Modulation by Cyclic Adenosine Monophosphate Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 794 - 802. [Abstract] [Full Text] |
||||
![]() |
P. E. MOORE, J. D. LAPORTE, J. H. ABRAHAM, I. N. SCHWARTZMAN, C. N. YANDAVA, E. S. SILVERMAN, J. M. DRAZEN, M. P. WAND, R. A. PANETTIERI Jr., and S. A. SHORE Polymorphism of the {beta}2-Adrenergic Receptor Gene and Desensitization in Human Airway Smooth Muscle Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2117 - 2124. [Abstract] [Full Text] |
||||
![]() |
V. P. Krymskaya, M. J. Orsini, A. J. Eszterhas, K. C. Brodbeck, J. L. Benovic, R. A. Panettieri Jr., and R. B. Penn Mechanisms of Proliferation Synergy by Receptor Tyrosine Kinase and G Protein-Coupled Receptor Activation in Human Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 546 - 554. [Abstract] [Full Text] |
||||
![]() |
C. K. Billington, I. P. Hall, S. J. Mundell, J.-L. Parent, R. A. Panettieri Jr., J. L. Benovic, and R. B. Penn Inflammatory and Contractile Agents Sensitize Specific Adenylyl Cyclase Isoforms in Human Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., November 1, 1999; 21(5): 597 - 606. [Abstract] [Full Text] |
||||
![]() |
M. J. Orsini, V. P. Krymskaya, A. J. Eszterhas, J. L. Benovic, R. A. Panettieri Jr., and R. B. Penn MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L479 - L488. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Amrani, A. L. Lazaar, and R. A. Panettieri Jr. Up-Regulation of ICAM-1 by Cytokines in Human Tracheal Smooth Muscle Cells Involves an NF-{kappa}B-Dependent Signaling Pathway That Is Only Partially Sensitive to Dexamethasone J. Immunol., August 15, 1999; 163(4): 2128 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Krymskaya, R. B. Penn, M. J. Orsini, P. H. Scott, R. J. Plevin, T. R. Walker, A. J. Eszterhas, Y. Amrani, E. R. Chilvers, and R. A. Panettieri Jr. Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation Am J Physiol Lung Cell Mol Physiol, July 1, 1999; 277(1): L65 - L78. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Haynes Jr., B. Obiako, P. Babal, and T. Stevens 5-(N-ethylcarboxamido)adenosine desensitizes the A2b-adenosine receptor in lung circulation Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1877 - H1883. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Penn, J.-L. Parent, A. N. Pronin, R. A. Panettieri Jr., and J. L. Benovic Pharmacological Inhibition of Protein Kinases in Intact Cells: Antagonism of Beta Adrenergic Receptor Ligand Binding by H-89 Reveals Limitations of Usefulness J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 428 - 437. [Abstract] [Full Text] |
||||
![]() |
R. B. Penn, R. M. Pascual, Y.-M. Kim, S. J. Mundell, V. P. Krymskaya, R. A. Panettieri Jr., and J. L. Benovic Arrestin Specificity for G Protein-coupled Receptors in Human Airway Smooth Muscle J. Biol. Chem., August 24, 2001; 276(35): 32648 - 32656. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |